Bolt Biotherapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
BOLT on Nasdaq
Location
900 Chesapeake Drive, Redwood City, CA

Insiders trading volume in the past year

Bolt Biotherapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Vivo Capital VIII, LLC 10%+ Owner $5.44M -$83K -1.5% Nov 21, 2023
Holdings A/S Novo 10%+ Owner $3.52M Jul 13, 2022
Edgar Engleman Director $1.97M -$176K -8.22% Nov 29, 2023
Edith A. Perez Chief Medical Officer $36.5K +$1.96K +5.67% Mar 4, 2024
William P. Quinn President, CEO and CFO, Director $34.5K +$9.08K +35.8% Jul 23, 2024
Sarah Nemec VP, Finance and PAO $10.8K Jul 23, 2024
Randall C. Schatzman Chief Executive Officer, Director $10.1K +$1.96K +24.1% Mar 4, 2024
Grant Yonehiro Chief Operating Officer $6.97K +$1.96K +39% Jul 23, 2024
Nicole Onetto Director Jun 12, 2024
David Dornan Chief Scientific Officer Feb 18, 2022
Brian O'callaghan Director Jun 12, 2024
Jakob Dupont Director Sep 3, 2024
Kathleen Laporte Director Jun 12, 2024
Laura Berner Director Jun 12, 2024
Frank D. Lee Director Jun 12, 2024
James Healy Director Jun 12, 2024
Richard A. Miller Director Jun 12, 2023
Mahendra Shah Director Jun 12, 2024

Recent Insider Transactions by Companies or Individuals for Bolt Biotherapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.